Bryan Roth | |
---|---|
Citizenship | USA |
Occupation | Professor |
Board member of | Executive Editor, Biochemistry |
Awards | Michael Hooker Distinguished Professor of Pharmacology (2006-) Goodman and Gilman Award for Receptor Pharmacology (2016) Member, National Academy of Medicine. Member , American Academy of Arts and Sciences.Contents |
Academic background | |
Alma mater | Carroll College, BA (1977) St. Louis University Medical School, MD, PhD (1983) |
Academic work | |
Discipline | Molecular Pharmacology |
Institutions | University of North Carolina Case Western Reserve University |
Bryan L. Roth is the Michael Hooker Distinguished Professor of Protein Therapeutics and Translational Proteomics,UNC School of Medicine. [1] He is recognized for his discoveries and inventions in the general areas of molecular pharmacology,GPCR structure,and function and synthetic neurobiology. He is a member of the American Academy of Arts and Sciences (AAAS) and the National Academy of Medicine (NAM)
Roth earned his B.A. in biology from Carroll College in 1977 and his M.D. and Ph.D. in biochemistry from Saint Louis University in 1983. After postdoctoral training at the National Institute of Mental Health (NIMH),he completed a psychiatry residency and fellowship at Stanford University in 1991. The same year,he was appointed Assistant Professor in the Department of Psychiatry at Case Western Reserve University. In 2003 he became a Professor of Biochemistry at Case Western Reserve University School of Medicine with secondary appointments in Psychiatry,Oncology,and Neurosciences. [2] In 2007 he was appointed as the Michael Hooker Distinguished Professor of Protein Therapeutics and Translational Proteomics,UNC School of Medicine. [3]
Roth has made contributions to the fields of G protein-coupled receptor (GPCR) pharmacology and neurobiology,particularly related to the function of serotonin and opioid receptors. His laboratory reported the structure of a serotonin receptor bound to the hallucinogenic drug,LSD. [4] [5] Other major works include identification of new probes and tools to detect GPCRs,obtained through directed evolution in animal cells, [6] developing receptors activated solely by a synthetic ligand (DREADDs),a chemogenetic platform used to direct selective,dose-dependent activation of a specific G protein subtype in vivo. [7] Thomas Insel,then Director of NIMH,stated in 2014 that DREADDs were one of the most important breakthrough technologies for the NIH BRAIN Initiative. [8] and have been used by more than a thousand labs for interrogating neural circuits responsible for simple and complex behaviors in animals.
Roth’s work has been recognized by Science Signaling as one of the ‘Signaling Breakthroughs of ‘2014’ [9] and 2016. [10] His DREADD technology was highlighted as one of the important advances in the past 10 years in Nature Chemical Biology. [11] Roth’s chemical biology discoveries have been highlighted by NIMH as one of the ‘Top 10 Research Advances of 2011’. [12] [13] Roth is a member of the American Academy of Arts and Sciences (AAAS) and the National Academy of Medicine (NAM). He received the Goodman and Gilman Award in Receptor Pharmacology from the American Society for Pharmacology and Experimental Therapeutics and was a 2018 Society for Neuroscience Presidential Special Lecture.
G proteins,also known as guanine nucleotide-binding proteins,are a family of proteins that act as molecular switches inside cells,and are involved in transmitting signals from a variety of stimuli outside a cell to its interior. Their activity is regulated by factors that control their ability to bind to and hydrolyze guanosine triphosphate (GTP) to guanosine diphosphate (GDP). When they are bound to GTP,they are 'on',and,when they are bound to GDP,they are 'off'. G proteins belong to the larger group of enzymes called GTPases.
An agonist is a chemical that activates a receptor to produce a biological response. Receptors are cellular proteins whose activation causes the cell to modify what it is currently doing. In contrast,an antagonist blocks the action of the agonist,while an inverse agonist causes an action opposite to that of the agonist.
Functional selectivity is the ligand-dependent selectivity for certain signal transduction pathways relative to a reference ligand at the same receptor. Functional selectivity can be present when a receptor has several possible signal transduction pathways. To which degree each pathway is activated thus depends on which ligand binds to the receptor. Functional selectivity,or biased signaling,is most extensively characterized at G protein coupled receptors (GPCRs). A number of biased agonists,such as those at muscarinic M2 receptors tested as analgesics or antiproliferative drugs,or those at opioid receptors that mediate pain,show potential at various receptor families to increase beneficial properties while reducing side effects. For example,pre-clinical studies with G protein biased agonists at the μ-opioid receptor show equivalent efficacy for treating pain with reduced risk for addictive potential and respiratory depression. Studies within the chemokine receptor system also suggest that GPCR biased agonism is physiologically relevant. For example,a beta-arrestin biased agonist of the chemokine receptor CXCR3 induced greater chemotaxis of T cells relative to a G protein biased agonist.
In biology,cell signaling is the process by which a cell interacts with itself,other cells,and the environment. Cell signaling is a fundamental property of all cellular life in prokaryotes and eukaryotes.
A receptor activated solely by a synthetic ligand (RASSL) or designer receptor exclusively activated by designer drugs (DREADD),is a class of artificially engineered protein receptors used in the field of chemogenetics which are selectively activated by certain ligands. They are used in biomedical research,in particular in neuroscience to manipulate the activity of neurons.
The 5-HT2A receptor is a subtype of the 5-HT2 receptor that belongs to the serotonin receptor family and is a G protein-coupled receptor (GPCR). The 5-HT2A receptor is a cell surface receptor,but has several intracellular locations.
P2Y receptors are a family of purinergic G protein-coupled receptors,stimulated by nucleotides such as adenosine triphosphate,adenosine diphosphate,uridine triphosphate,uridine diphosphate and UDP-glucose.To date,8 P2Y receptors have been cloned in humans:P2Y1,P2Y2,P2Y4,P2Y6,P2Y11,P2Y12,P2Y13 and P2Y14.
EGF-like module-containing mucin-like hormone receptor-like 1 also known as F4/80 is a protein encoded by the ADGRE1 gene. EMR1 is a member of the adhesion GPCR family. Adhesion GPCRs are characterized by an extended extracellular region often possessing N-terminal protein modules that is linked to a TM7 region via a domain known as the GPCR-Autoproteolysis INducing (GAIN) domain.
EGF-like module-containing mucin-like hormone receptor-like 2 also known as CD312 is a protein encoded by the ADGRE2 gene. EMR2 is a member of the adhesion GPCR family. Adhesion GPCRs are characterized by an extended extracellular region often possessing N-terminal protein modules that is linked to a TM7 region via a domain known as the GPCR-Autoproteolysis INducing (GAIN) domain.
EGF-like module-containing mucin-like hormone receptor-like 3 is a protein encoded by the ADGRE3 gene. EMR3 is a member of the adhesion GPCR family. Adhesion GPCRs are characterized by an extended extracellular region often possessing N-terminal protein modules that is linked to a TM7 region via a domain known as the GPCR-Autoproteolysis INducing (GAIN) domain.
5-Hydroxytryptamine receptor 2B (5-HT2B) also known as serotonin receptor 2B is a protein that in humans is encoded by the HTR2B gene. 5-HT2B is a member of the 5-HT2 receptor family that binds the neurotransmitter serotonin (5-hydroxytryptamine,5-HT). Like all 5-HT2 receptors,the 5-HT2B receptor is Gq/G11-protein coupled,leading to downstream activation of phospholipase C.
5-Hydroxytryptamine (serotonin) receptor 5A,also known as HTR5A,is a protein that in humans is encoded by the HTR5A gene. Agonists and antagonists for 5-HT receptors,as well as serotonin uptake inhibitors,present promnesic (memory-promoting) and/or anti-amnesic effects under different conditions,and 5-HT receptors are also associated with neural changes.
G protein-coupled receptor 64 also known as HE6 is a protein encoded by the ADGRG2 gene. GPR64 is a member of the adhesion GPCR family. Adhesion GPCRs are characterized by an extended extracellular region often possessing N-terminal protein modules that is linked to a TM7 region via a domain known as the GPCR-Autoproteolysis INducing (GAIN) domain.
G protein-coupled receptor 126 also known as VIGR and DREG is a protein encoded by the ADGRG6 gene. GPR126 is a member of the adhesion GPCR family. Adhesion GPCRs are characterized by an extended extracellular region often possessing N-terminal protein modules that is linked to a TM7 region via a domain known as the GPCR-Autoproteolysis INducing (GAIN) domain.
G protein-coupled receptor 128 is a protein encoded by the ADGRG7 gene. GPR128 is a member of the adhesion GPCR family. Adhesion GPCRs are characterized by an extended extracellular region often possessing N-terminal protein modules that is linked to a TM7 region via a domain known as the GPCR-Autoproteolysis INducing (GAIN) domain.
G protein-coupled receptor 112 is a protein encoded by the ADGRG4 gene. GPR112 is a member of the adhesion GPCR family. Adhesion GPCRs are characterized by an extended extracellular region often possessing N-terminal protein modules that is linked to a TM7 region via a domain known as the GPCR-Autoproteolysis INducing (GAIN) domain.
G protein-coupled receptor 114 is a protein encoded by the ADGRG5 gene. GPR114 is a member of the adhesion GPCR family. Adhesion GPCRs are characterized by an extended extracellular region often possessing N-terminal protein modules that is linked to a TM7 region via a domain known as the GPCR-Autoproteolysis INducing (GAIN) domain.
G-protein coupled receptor 97 also known as adhesion G protein-coupled receptor G3 (ADGRG3) is a protein that in humans is encoded by the ADGRG3 gene. GPR97 is a member of the adhesion GPCR family. Adhesion GPCRs are characterized by an extended extracellular region often possessing N-terminal protein modules that is linked to a TM7 region via a domain known as the GPCR-Autoproteolysis INducing (GAIN) domain.
G protein-coupled receptor 56 also known as TM7XN1 is a protein encoded by the ADGRG1 gene. GPR56 is a member of the adhesion GPCR family. Adhesion GPCRs are characterized by an extended extracellular region often possessing N-terminal protein modules that is linked to a TM7 region via a domain known as the GPCR-Autoproteolysis INducing (GAIN) domain.
Chemogenetics is the process by which macromolecules can be engineered to interact with previously unrecognized small molecules. Chemogenetics as a term was originally coined to describe the observed effects of mutations on chalcone isomerase activity on substrate specificities in the flowers of Dianthus caryophyllus. This method is very similar to optogenetics;however,it uses chemically engineered molecules and ligands instead of light and light-sensitive channels known as opsins.